Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Shipping delays, supply chain expansions ding Moderna’s COVID-19 vaccine business

Moderna has been biotech’s biggest growth story in 2021, but the company’s rate of expansion slowed considerably in recent months as shipping delays and a supply chain scale-up took a toll. In the third quarter, the mRNA biotech delivered 208 million COVID-19 vaccine doses worldwide, a figure Chief Financial Officer David Meline called a “relatively […]

For pharma marketers, mobile devices reign supreme. But for how long?

Pharma marketers take note. Looking for higher click engagement? Run ads Monday and Tuesday. If higher conversion engagement is the goal, though, then it’s Tuesday and Saturday. In terms of the best time—the peak is around 3 p.m. for click engagement and 9 p.m. for conversion, all according to advertising software company Viant Technology, With […]

ASH: Chasing AbbVie and J&J’s Imbruvica, BeiGene’s Brukinsa fleshes out competitive leukemia data again

As the third player to enter the BTK realm, BeiGene has had its eyes fixated on AbbVie and Johnson & Johnson’s market leader Imbruvica. After clinical wins in smaller indications, the Chinese-American biotech has once again posted competitive data for Brukinsa—this time in the all-important newly diagnosed leukemia. In previously untreated patients with chronic lymphocytic […]

After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says

As Novo Nordisk worked to advance its suite of next-gen medicines back in 2016 and 2017, the company was in a phase of “relatively low growth,” CEO Lars Fruergaard Jørgensen acknowledges. Now, thanks to new launches, things have changed. After the 2020 and 2021 rollouts for diabetes tablet Rybelsus and obesity medicine Wegovy, respectively, Novo appears firmly on a growth […]

Incyte investigates all batches of new eczema cream Opzelura after reports of ‘texture problem’

Incyte has only taken the first step in its rollout of topical atopic dermatitis drug Opzelura, but it has already hit a manufacturing problem that that threatens to derail the key launch. Incyte is now investigating all its Opzelura batches after reports of a “texture problem” with both its samples and commercial products, Barry Flannelly, […]

Merck will support Saudi Arabia effort to build biologics manufacturing operations

Merck has signed on to help SaudiVax of Saudi Arabia design and construct a multimodality biologics manufacturing facility as part of the country’s efforts to provide a more localized production infrastructure for the Middle East, Northern Africa region. SaudiVax, which is touted as the first vaccine biotech in Saudi Arabia, committed earlier this year to […]

Amgen’s Lumakras off to a strong start toward analyst’s blockbuster predictions pegged to combo potential

Approved in May—three months ahead of schedule—and becoming a first-in-class treatment for a certain type of lung cancer previously thought to be undruggable, Amgen’s Lumakras is off to a promising start. On Tuesday, when the company reported third-quarter earnings, Lumakras came in at $36 million for a cumulative $45 million since it launched for non-small cell […]

Almirall illuminates the emotional side of psoriasis in new awareness campaign

Psoriasis impacts more than the skin—it often takes a toll on a patient’s psyche. Besides dealing with the characteristic red and scaly rash, patients can suffer from embarrassment, anxiety, depression, social isolation and stigma. Barcelona, Spain-based Almirall, which markets dermatological medicines, wants to shine a light on that often-hidden side of the disease in its […]

Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease

Novartis and cardiovascular disease patient advocacy group, Global Heart Hub, have joined forces to make the dangers atherosclerotic cardiovascular disease (ASCVD) more visible through the “Invisible Nation” initiative. The program is called “The Invisible Nation,” because despite heart disease being billed as “the world’s No. 1 killer” and ASCVD accounting for 85% of cardiovascular-related deaths, […]

AbbVie’s Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia closely behind

For patients with presbyopia, or age-related blurry near vision, wearing glasses or contact lens has long been the mainstay correction method. Thanks to a new FDA approval, they now have an eye drop option. Friday, the FDA green-lit AbbVie’s Vuity for presbyopia, making the once-daily pilocarpine solution the first eye drop for the common eye condition. […]

Johnson & Johnson, AbbVie, Teva and Endo score industry’s first opioid trial win

As U.S. opioid litigation has evolved in recent years, drugmakers have watched the backlog of lawsuits grow as they’ve consistently failed to pick up any trial wins. This week in California, four companies finally scored a victory. A California judge ruled in favor of Johnson & Johnson, AbbVie, Teva and Endo in a high-profile case […]

In the CDMO industry’s expansion blitz, Samsung Biologics goes full speed ahead with ‘Super Plant,’ plans to grow global footprint

In the biopharma manufacturing industry’s race for expansion, few companies are as equipped for the sprint like Samsung Biologics. Since it was established in 2011 and in short order became a CDMO force, Samsung has sought to do everything quickly. A conversation with CEO John Rim has a consistent theme—speed. “We scale up very quickly. Speed, […]